Climb Bio Inc. (CLYM)
NASDAQ: CLYM
· Real-Time Price · USD
1.20
-0.04 (-3.23%)
At close: Jul 01, 2025, 3:59 PM
1.20
0.00%
After-hours: Jul 01, 2025, 06:13 PM EDT
-3.23% (1D)
Bid | 1.17 |
Market Cap | 81.09M |
Revenue (ttm) | n/a |
Net Income (ttm) | -73.9M |
EPS (ttm) | -1.78 |
PE Ratio (ttm) | -0.67 |
Forward PE | -1.3 |
Analyst | Buy |
Ask | 1.26 |
Volume | 172,602 |
Avg. Volume (20D) | 232,322 |
Open | 1.24 |
Previous Close | 1.24 |
Day's Range | 1.19 - 1.25 |
52-Week Range | 1.05 - 9.21 |
Beta | -0.16 |
About CLYM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLYM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLYM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+12.1%
Climb Bio shares are trading higher after Oppenhei...
Unlock content with
Pro Subscription
7 months ago
+7.12%
Climb Bio shares are trading higher. The company announced it appointed a new chair to its board of directors.